Generic Name and Formulations:
Ketoconazole 2%; topical gel (anhydrous).
Indications for XOLEGEL:
Topical treatment of seborrheic dermatitis in immunocompetent patients.
Apply a thin layer to affected area(s) once daily for 2 weeks. Wash hands before and after use. Do not wash treated areas for at least 3 hours after application. Wait at least 20 mins before applying cosmetics, sunscreen, etc.
Avoid eyes, lips, mucous membranes. If irritation occurs or if disease worsens, then the use of the medication should be discontinued. Product is flammable (avoid open flames, smoking while applying). Pregnancy (Cat.C). Nursing mothers.
Application site burning, headache.
Gel—45g; Xolegel Duo—1 kit (15g gel + 4oz Xolex shampoo [zinc pyrithione 1%]); or (15g gel + 1.7oz Head & Shoulders shampoo [zinc pyrithione 1%])
Endocrinology Advisor Articles
- Insulin Analogs vs Regular Human Insulin for Type 2 Diabetes
- Trends in Bisphosphonate Use and Hip Fracture Rates in Denmark
- Gender-Affirming Hormonal Treatment and Long-Term Bone Safety
- Primary Characteristics of PCOS Predictive of Obstetric Complications
- Maternal Thyroid Function in Pregnancy Linked to Childhood Risk for Disease
- Sleep Habits Affect Insulin Sensitivity in Adolescents With Overweight, Obesity
- Levothyroxine Associated With Increased Mortality in Patients With Heart Failure
- Head-to-Head Comparison of Professional vs Personal CGM Systems in T1D
- Dual vs Triple Therapy for Metformin Treatment Intensification in Type 2 Diabetes
- Familial Hypercholesterolemia: An Underdiagnosed Disease Gets a Second Look
- FDA Committee Votes on Oral T1D Treatment Sotagliflozin
- Elevated Plasma Agouti-Related Protein May Be a Marker for Cushing Disease
- Therapeutic Effect of Long-Chain PUFA Omega 3 Supplementation in Obese Children
- Poor Health Outcomes Associated With Fear of Crime, Violence Among College Students of Color
- Safety of PCSK9 Inhibitors After Heart Transplantation Examined